Literature DB >> 27849392

Effects of Nigella sativa on apoptosis and GABAA receptor density in cerebral cortical and hippocampal neurons in pentylenetetrazol induced kindling in rats.

I Meral1, M Esrefoglu2, K A Dar3, S Ustunova1, M S Aydin2, M Demirtas1, Y Arifoglu4.   

Abstract

We investigated the effects of Nigella sativa on apoptosis and gamma-aminobutyric acid (GABAA) receptor density in cerebral cortical and hippocampal neurons in a pentylenetetrazol (PTZ)-induced kindling model in rats. The PTZ kindling model was produced by injecting PTZ in subconvulsive doses to rats on days 1, 3, 5, 8, 10, 12, 15, 17, 19, 22 and 24 of the study into animals of PTZ treated (PTZ) and PTZ + N. sativa treated (PTZ + NS) groups. Clonic and tonic seizures were induced by injecting a convulsive dose of PTZ on day 26 of the study. Rats in the PTZ + NS group were treated also with a 10 mg/kg methanolic extract of N. sativa 2 h before each PTZ injection. Rats in the control group were treated with 4 ml/kg saline. The number of neurons that expressed GABAA receptors in the hippocampus and cerebral cortex of rats in the PTZ and PTZ + NS groups increased significantly. There was no significant difference in the number of GABAA receptors between the PTZ and PTZ + NS groups. GABAA receptor density of the neurons in the cerebral cortex, but not hippocampus, was increased in PTZ group compared to controls. We observed a significant increase in the number of apoptotic neurons in the cerebral cortex of rats of both the PTZ and PTZ + NS groups compared to controls. We observed a significant decrease in the number of the apoptotic neurons in the cerebral cortex of rats in the PTZ + NS group compared to the PTZ group. N. sativa treatment ameliorated the PTZ induced neurodegeneration in the cerebral cortex as reflected by neuronal apoptosis and neuronal GABAA receptor frequency.

Entities:  

Keywords:  GABAA receptor; Nigella sativa; apoptosis; brain; cerebral cortex; epilepsy; hippocampus; kindling model; pentylenetetrazol

Mesh:

Substances:

Year:  2016        PMID: 27849392     DOI: 10.1080/10520295.2016.1245866

Source DB:  PubMed          Journal:  Biotech Histochem        ISSN: 1052-0295            Impact factor:   1.718


  3 in total

Review 1.  Molecular signaling pathway targeted therapeutic potential of thymoquinone in Alzheimer's disease.

Authors:  Fabiha Zaheen Khan; Md Shaki Mostaid; Mohd Nazmul Hasan Apu
Journal:  Heliyon       Date:  2022-07-05

Review 2.  Thymoquinone: Review of Its Potential in the Treatment of Neurological Diseases.

Authors:  Faheem Hyder Pottoo; Abdallah Mohammad Ibrahim; Ali Alammar; Rida Alsinan; Mahdi Aleid; Ali Alshehhi; Muruj Alshehri; Supriya Mishra; Noora Alhajri
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-27

3.  Neuromodulatory Effect of Thymoquinone in Attenuating Glutamate-Mediated Neurotoxicity Targeting the Amyloidogenic and Apoptotic Pathways.

Authors:  Ibram Amin Fouad; Nadia Mohamed Sharaf; Ragwa Mansour Abdelghany; Nesrine Salah El Dine El Sayed
Journal:  Front Neurol       Date:  2018-04-13       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.